Kristie L. Kahl

On behalf of the National Pancreas Foundation, Dr. Diane Simeone offers insight into early detection options for those at increased risk of pancreatic cancer, including surveillance and screening.

Treatment with a novel immuno-oncology therapy demonstrated a manageable safety profile with preliminary efficacy in patients with metastatic castration-resistant prostate cancer.

In this episode of the “CURE Talks Cancer” podcast, we spoke with television journalist Katie Couric and Susan G. Komen CEO Paula Schneider about their experiences with cancer, and the advice they offered their pre-cancer selves.

In this episode of the “CURE Talks Cancer” podcast, we looked back on CURE’s Lung Cancer Heroes event and recognized each winner that helps bring together the lung cancer community to raise awareness.

Organized as a virtual event, the DONNA Foundation’s 2021 National Marathon to Finish Breast Cancer will allow participants to run in their neighborhoods — or on their treadmills.

How does a metastatic cancer diagnosis affect families, especially children? CURE® spoke with Kate Watson, a patient ambassador for METAvivor, about the tricky balance of protecting and empowering kids.

After granting accelerated approval in 2018, the Food and Drug Administration approved Venclexta in combination with Vidaza, Dacogen or low dose cytarabine in newly diagnosed patients with AML.

“The combination of cabozantinib (Cabometyx) and atezolizumab (Tecentriq) demonstrated encouraging clinical activity in previously untreated patients with advanced ccRCC,” Dr. Sumanta Kumar Pal, co-director of the Kidney Cancer Program at City of Hope in California, said during a presentation of the clear cell renal cell carcinoma cohort.

VERU Inc. announced it has completed enrollment of 40 men with metastatic prostate cancer who have become resistant to at least one androgen receptor targeting agent for its phase 2 study of VERU-111.

The PARP inhibitor Lynparza reduced the risk for death by 31% in men with metastatic castration-resistant prostate cancer compared with Xtandi or Zytiga plus the corticosteroid prednisone.

In this episode of the “CURE Talks Cancer” podcast, we spoke with Dr. Jeremy Brauer, on behalf of the Skin Cancer Foundation, about current treatment strategies and the future of the disease.

Chadwick Boseman, known best for his role in “Black Panther,” has died after receiving a colon cancer diagnosis four years ago.